Literature DB >> 12432424

The Scoring Clinical Index for Onychomycosis (SCIO index).

A Y Sergeev1, A K Gupta, Y V Sergeev.   

Abstract

Onychomycosis is a common disease, and there are a number of factors that may affect the duration and dosage of treatment including the type of onychomycosis, the area and thickness of nail involvement, the age of the patient, and the location of the digit that is affected. We report a composite index, the Scoring Clinical Index for Onychomycosis (SCIO) that combines these factors to give an index of the overall severity of onychomycosis. The use of the SCIO may have treatment implications; by matching patients with similar SCIO scores, it may be possible to better compare the clinical response to therapy.

Entities:  

Mesh:

Year:  2002        PMID: 12432424

Source DB:  PubMed          Journal:  Skin Therapy Lett        ISSN: 1201-5989


  8 in total

1.  Correlation of clinical characteristics, by calculation of SCIO index, with the laboratory diagnosis of onychomycosis.

Authors:  Eleonora Dubljanin; Aleksandar Dzamic; Isidora Vujcic; Stefan Mijatovic; Teodora Crvenkov; Sandra Sipetic Grujicic; Ivana Colovic Calovski
Journal:  Braz J Microbiol       Date:  2022-01-08       Impact factor: 2.476

2.  Prevalence and Characteristics of Onychomycosis in Patients with Knee Osteoarthritis: A Single-centre Prospective Cross-sectional Study.

Authors:  Soyun Cho; Hanjae Lee; Ji Ye Hwang; Jong Soo Choi; Hyeong Jik Kim; Tae Woo Kim; Seung-Baik Kang
Journal:  Acta Derm Venereol       Date:  2021-08-25       Impact factor: 3.875

3.  [Effect of 0.9-ms 1064-nm Nd:YAG laser combined with itraconazole for treatment of toenail onychomycosis].

Authors:  Ze-Min Zhong; Ye-Mei Yang; Si-Tong Zhou; Yong-Xuan Hu; Zu-Hao Mao; Zhong Wu; Xue Han; Kang-Xing Liu; Shi-Yun Hunag; Yan-Qing Hu; Yan Lu; Xian-Yi Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-03-20

4.  A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen® dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis.

Authors:  Manoj Parekh; Girisha Ramaiah; Prachi Pashilkar; Ranjani Ramanujam; Peter Johnston; Leodevico L Ilag
Journal:  BMC Complement Altern Med       Date:  2017-09-18       Impact factor: 3.659

5.  Efficacy of Two-Stage Treatment of Onychomycosis Using a Long-Pulsed Nd:YAG 1064-nm Laser.

Authors:  Shan Zhong; Guan-Ting Lin; Jun-Ying Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-16       Impact factor: 2.629

6.  Different Numbers of Long-Pulse 1064-nm Nd-YAG Laser Treatments for Onychomycosis: A Pilot Study.

Authors:  Rui-Na Zhang; Feng-Lin Zhuo; Dong-Kun Wang; Li-Zhi Ma; Jun-Ying Zhao; Lin-Feng Li
Journal:  Biomed Res Int       Date:  2020-01-20       Impact factor: 3.411

7.  Treatment of Onychomycosis - a Clinical Study.

Authors:  Laura Pajaziti; Ermira Vasili
Journal:  Med Arch       Date:  2015-06-10

8.  Self-controlled Study of Onychomycosis Treated with Long-pulsed Nd:YAG 1064-nm Laser Combined with Itraconazole.

Authors:  Yan Li; Jing Xu; Jun-Ying Zhao; Feng-Lin Zhuo
Journal:  Chin Med J (Engl)       Date:  2016-08-20       Impact factor: 2.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.